Sort
48,018 grants matching “immunotherapy”
SPORE in Prostate Cancer
$1,881,134Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2025 · CA
Project 1: Enabling innate-adaptive immune crosstalk by improving NK cell trafficking and resistance to suppression
$1,879,957Dean A Lee · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,879,702Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AI
Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment
$1,877,772George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,877,686Washington University · U01 · FY2003 · AI
SPORE in Prostate Cancer
$1,877,328William George Nelson · Johns Hopkins University · P50 · FY2014 · CA
DNA Sequencing and FACS Core Facilities
$1,877,132Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Biology and Therapy of High Risk Neuroblastoma
$1,876,546Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2013 · CA
Mixed Hematopoietic Chimerism after Stem Cell Allografts
$1,876,346Fred Hutchinson Cancer Research Center · P01 · FY2004 · CA
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan
$1,876,314Tim Van Opijnen · Boston College · U01 · FY2020 · AI
PROTECTIVE AND DAMAGING LYMPHOCYTE RESPONSES IN THE LUNG
$1,875,711Trudeau Institute, Inc. · P01 · FY2005 · HL
Immunohistochemical and genomic analysis of tumors
$1,875,642Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression
$1,874,803Sylvia Katina Plevritis · Stanford University · U54 · FY2020 · CA
Enhancing T Cell Therapy of Cancer
$1,874,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA
MPS Models Development and Validation Core
$1,873,030Tracy L Young-Pearse · Brigham And Women'S Hospital · U54 · FY2025 · AG
NEI Genetic Engineering Core
$1,872,099Lijin Dong · National Eye Institute · ZIC · FY2025 · EY
Post-Viral Syndromes
$1,871,800Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
SPORE In Prostate Cancer
$1,871,390Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2013 · CA
Elafin Therapy for Pulmonary Arterial Hypertension
$1,870,546Marlene Rabinovitch · Stanford University · P01 · FY2018 · HL
Integrative-omics and Systems Biology across the atopic march
$1,869,376Rasika Mathias · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Characterization of the Osteosarcoma Genome
$1,869,292Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,869,132David J Odde · University Of Minnesota · P01 · FY2023 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,869,132David J Odde · University Of Minnesota · P01 · FY2022 · CA
Colon Cancer Family Registry Cohort
$1,868,610Mark A Jenkins · University Of Melbourne · U01 · FY2022 · CA
Gene Therapy Using Hematopoietic Stem Cells
$1,868,463Donald B Kohn · University Of California Los Angeles · P01 · FY2010 · HL